Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL3421887

CC(=O)Oc1ccc(-c2cccc(S)c2-c2ccc(OC(C)=O)cc2)cc1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.40
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
BACE1 P56817 4/20 0.39
LMNA P02545 3/20 0.39
GAA P10253 1/20 0.39
ELANE P08246 1/20 0.38
PTGS2 P35354 2/20 0.38
TDP1 Q9NUW8 2/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
APAF1 O14727 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GAPDH P04406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3186467 0.89 HSD17B10 (0.36) HSD17B10MAPTPOLBPKMBACE1
SCHEMBL3418507 0.88 HSD17B10 (0.50) HSD17B10MAPTPOLBPKMBACE1
Trifluoromethanesulfonic Acid SCHEMBL7122599 0.86 ELANE (0.45) MAPTLMNAGAAELANETDP1
Trifluoromethanesulfonic Acid SCHEMBL3143639 0.86 ENPP1 (0.46) MAPTBACE1LMNAPTGS2TDP1
Trifluoromethanesulfonic Acid SCHEMBL216880 0.84 PPARG (0.36) MAPTLMNATDP1MEN1KMT2A
SCHEMBL3197385 0.83 FPR1 (0.32) HSD17B10MAPTPOLBPKMBACE1
Trifluoromethanesulfonic Acid SCHEMBL1088677 0.82 ENPP1 (0.43) POLBPTGS2MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL977832 0.80 BACE1 (0.38) MAPTPKMBACE1MEN1KMT2A
Trifluoromethanesulfonic Acid SCHEMBL3130162 0.80 ENPP1 (0.42) PTGS2
Trifluoromethanesulfonic Acid SCHEMBL3134866 0.80 MAPT (0.39) HSD17B10MAPTPOLBBACE1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070111138-A1 Photoactive compounds MERCK PATENT GMBH (DE) 2007-05-17 US claimed
US-9146467-B2 Coating compositions MERCK PATENT GMBH (DE) 2015-09-29 US disclosed
US-20130236833-A1 COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (US) 2013-09-12 US disclosed
US-8455176-B2 Coating composition AZ ELECTRONIC MATERIALS USA CORP. (US) 2013-06-04 US disclosed
US-20100119972-A1 COATING COMPOSITION MERCK PATENT GMBH (DE) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119972-A1 COATING COMPOSITION S100A9, CAPG, C5 HSD17B10 3969/4885MAPT 488/4885POLB 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.